How Much Money You'd Have Now If You Invested $1,000 in Eli Lilly 10 Years Ago

_{^{Photo by Transly Translation Agency on Unsplash}}

Eli Lilly & Co. is one of the world’s most valuable drug manufacturers, and its recent earnings results have been impressive. The company’s success can be attributed to its popular products, such as Mounjaro, a prescription medication for Type 2 diabetes, and Zepbound, a prescription medicine for weight loss.

Zepbound was approved by the U.S. Food and Drug Administration in November 2023 as a treatment for weight management and obesity. In its first full quarter in the U.S. market, Zepbound brought in $517.4 million in revenue, and in the second quarter, it generated $1.24 billion in U.S. revenue.

The demand for weight loss drugs is on the rise around the world, with the global market for obesity medication expected to hit $105 billion in 2030. Drug manufacturers such as Eli Lilly and Novo Nordisk are racing to meet this demand, investing billions to build new manufacturing plants to boost supply of the popular medications.

But how much would you have made if you had invested in Eli Lilly 10 years ago? CNBC calculated that a $1,000 investment in the company would be worth $13,143 today, based on the company’s August 7 closing share price of $772.14.

This represents a 1,214% increase over the past decade, making Eli Lilly a highly successful investment. Even a $1,000 investment five years ago would be worth $6,939 today, a 594% increase.

The company’s success can be attributed to its ability to adapt to changing market conditions and its commitment to innovation. With its strong portfolio of products and its ongoing investments in research and development, Eli Lilly is well-positioned for continued success in the future.

Image: Pharmaceutical products in a laboratory

Eli Lilly’s success is not limited to its financial performance. The company has also made significant contributions to the field of medicine, with its products improving the lives of millions of people around the world.

The company’s commitment to innovation is evident in its research and development pipeline, which includes a number of promising new products. With its strong track record of success and its ongoing investments in innovation, Eli Lilly is well-positioned for continued growth and success in the future.

Image: A graph showing the stock market performance of Eli Lilly

Investing in the stock market can be a risky business, but for those who are willing to take the risk, the potential rewards can be significant. With its strong track record of success and its ongoing investments in innovation, Eli Lilly is a company that is worth considering for any investment portfolio.

Image: An investor looking at a stock market graph

However, it’s always important to do your own research and consider your own financial goals and risk tolerance before making any investment decisions. It’s also important to diversify your portfolio and not put all your eggs in one basket.

Image: A diversified investment portfolio

In conclusion, Eli Lilly is a highly successful company with a strong track record of innovation and financial performance. With its commitment to research and development and its ongoing investments in new products, the company is well-positioned for continued growth and success in the future. For those who are willing to take the risk, investing in Eli Lilly could be a lucrative decision.

Image: The Eli Lilly logo

Image: An investor looking at financial news

For more information on investing in the stock market and how to build a diversified portfolio, check out our Money Report. And for more information on Eli Lilly and its products, check out the company’s website.

Image: The Money Report logo

Image: A newsletter sign-up form

Image: Social media logos